Saroja Pharma Industries India Management
Management criteria checks 2/4
Saroja Pharma Industries India's CEO is Biju Nair, appointed in May 2023, has a tenure of 1.58 years. directly owns 72.05% of the company’s shares, worth ₹161.78M. The average tenure of the management team and the board of directors is 1.6 years and 1.6 years respectively.
Key information
Biju Nair
Chief executive officer
₹3.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.6yrs |
| CEO ownership | 72.0% |
| Management average tenure | 1.6yrs |
| Board average tenure | 1.6yrs |
Recent management updates
CEO
Biju Nair (54 yo)
1.6yrs
Tenure
₹3,840,000
Compensation
Mr. Biju Gopinathan Nair has been Chairman and Managing Director of Saroja Pharma Industries India Limited since May 05, 2023 and an Executive Director since January 14, 2019. He highly motivated and enthu...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 1.6yrs | ₹3.84m | 72.05% ₹ 161.8m | |
| Whole Time Director | no data | ₹1.56m | 0.97% ₹ 2.2m | |
| Chief Financial Officer | 1.6yrs | no data | no data | |
| Company Secretary & Compliance Officer | 1.8yrs | no data | no data |
1.6yrs
Average Tenure
Experienced Management: SAROJA's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 5.9yrs | ₹3.84m | 72.05% ₹ 161.8m | |
| Whole Time Director | 1.6yrs | ₹1.56m | 0.97% ₹ 2.2m | |
| Non-Executive & Independent Director | 1.6yrs | no data | no data | |
| Non-Independent & Non-Executive Director | 1.8yrs | no data | 0.000050% ₹ 112.3 | |
| Non-Executive & Independent Director | 1.6yrs | no data | no data | |
| Non-Executive & Independent Director | 1.6yrs | no data | no data |
1.6yrs
Average Tenure
42.5yo
Average Age
Experienced Board: SAROJA's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:40 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Saroja Pharma Industries India Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|